An orally delivered, live‐attenuated Edwardsiella ictaluri vaccine efficiently protects channel catfish fingerlings against multiple Edwardsiella ictaluri field isolates

Abstract

AbstractThe commercial channel catfish (Ictalurus punctatus) industry is adversely impacted by enteric septicemia of catfish (ESC), caused by the Gram‐negative enteric rod Edwardsiella ictaluri. In efforts to develop more effective management strategies, the use of a live‐attenuated E. ictaluri isolate as an oral vaccine was investigated. The utility and broad application of a vaccine is dependent on the protection offered against multiple field isolates. Immunization trials, followed by bacterial challenge with archived virulent E. ictaluri isolates from the catfish farming region of the southeastern United States, were conducted over a 3‐year period. These isolates were archived from 1993 to 2016 and included representatives from nonvaccinated and vaccinated populations of diseased channel catfish in Mississippi, an isolate from nonvaccinated hybrid catfish raised in Mississippi, and an isolate from nonvaccinated channel catfish from Alabama. Molecular characterization of the isolates revealed a high degree of genetic similarity evidenced by repetitive sequence‐mediated polymerase chain reaction (rep‐PCR) fingerprinting and virulence gene amplification, suggesting that the population of E. ictaluri within catfish aquaculture in Mississippi and Alabama has been genetically stable over time. Plasmid profiling revealed the existence of at least four distinct plasmids among field isolates. Nevertheless, the E. ictaluri vaccine protected fish against all isolates, irrespective of heterogeneous or homogeneous plasmid profiles. In addition, plasmid profiles were supported by antimicrobial sensitivity testing, indicating that the E. ictaluri vaccine strain does not carry natural or plasmid‐mediated multidrug resistance to the three antibiotics approved for use in U.S. food fish aquaculture. Challenge data from this study argue against the need for multivalent E. ictaluri vaccines to account for presumed antigenic or genetic variation among wild‐type E. ictaluri isolates as the vaccine was effective against all archived isolates.